DERMATOLOGYApril 2015Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks
PHARMACOLOGYJuly 2014Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies
DERMATOLOGYOctober 2012Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab’ certolizumab pegol: results of a phase II randomized placebo controlled trial with a re-treatment extension
DERMATOLOGYOctober 2012Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study
DERMATOLOGYOctober 2012A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis
